Thu, Jan 18, 2024
On Thursday, Sun Pharma shares ended weaker by Rs 14.3, or 1.1 per cent, at Rs 1,299.3 apiece.
More >
Wed, Jan 17, 2024
Under the terms of the agreement, Bayer has granted non-exclusive rights to Sun Pharma to market and distribute a second Finerenone product under the brand name Lyvelsa. Finerenone was first launched by Bayer under the brand name Kerendia in 2022.
Wed, Jan 03, 2024
Sun Pharma hits a new high after acquiring Israel's Libra Merger, consolidating its presence in the region. This follows a recent US investment in Lyndra Therapeutics. We break down the deals and their potential impact on Sun Pharma's future.
Thu, Jun 27, 2019
Sun Pharmaceutical Industries Ltd on Thursday announced that one of its wholly-owned subsidiaries has entered into a licensing agreement with a subsidiary of China Medical System Holdings Ltd.
Sun Pharma stock has validated the Hammer candle pattern formed on the weekly chart (moved above candle’s high) which is confirmation of the bullish reversal.
Wed, Jun 05, 2019
Now that, PM Modi is back in office investors have entered to June 2019, where focus has shifted towards RBI monetary policy, thus one has to make most of stock markets.
Wed, May 29, 2019
Sun Pharma released its Q4FY19 performance in which the company’s net profit came in at Rs 636 crore.
Tue, May 14, 2019
Sensex closes 227 points up, Nifty at 11,318; Sun Pharma, Vedanta, Delta Corp top gainers. Watch this video to know more.
Tue, Jan 29, 2019
Watch this segment to know the top stocks for investment before budget 2019.
Fri, Jan 18, 2019
Sr. Equity Analyst, Rohit Singre, LKP Securities told Zee Business Online, ''The stock is down because of news, however technically it is weak right now. Investors are suggested to avoid until further clearance on the allegations.''
The whistleblower alleged in a 172-page complaint that Sun Pharma`s distributor Aditya Medisales had transactions worth more than 58 billion rupees ($815 million) with Suraksha Realty, controlled by Sun`s co-promoter Sudhir Valia, a report by Moneylife magazine said.
The whistleblower complaint alleges that an Indian pharmaceutical manufacturer Aditya Medisales Ltd had transactions with Suraksha Realty, controlled by Sun Pharma`s co-promoter, Sudhir Valia, the report stated.
Wed, Jan 02, 2019
The 30 share Sensex closed at Rs 35,891.72, jumping 363 points or 1 per cent down. While NSE Nifty50 fell 117 points or 1.1 per cent to close at Rs 10,792.50.
Mon, Dec 03, 2018
There was massive bloodbath in the company and the shares crashed by 11.39% in an early trade today with an intraday low of Rs 441.95.
Mon, Nov 26, 2018
In a regulatory filing, Sun Pharma said "the settlements extend to all claims brought by the Direct Purchaser Plaintiffs".
Wed, Nov 14, 2018
Sun Pharma saw losses in its book on the back of one-time settlement of Rs 1,214.38 crore with respect to Modafinil antitrust litigation in the US.
Tue, Sep 25, 2018
Continuous selling pressure from the foreign institutional investors (FII), rupee depreciation, adverse macroeconomic factors, uncertainty on national and state election, and overvalued stocks and indices – all these factors together can lead to a correction in the market.
Wed, Jul 18, 2018
This is the first US Food and Drug Administration (USFDA) approval for a product from the company's Halol facility after receipt of Establishment Inspection Report (EIR) in June 2018, Sun Pharma said in a statement.
Thu, Jul 12, 2018
Sun Pharma said its arm DUSA has filed trade secret misappropriation and tortious interference claims in an ongoing patent infringement lawsuit against Biofrontera.
Thu, Jun 28, 2018
While rupee depreciation doesn't bode well for importers, it brings cheers for exporters who earn their revenues in rupees. We have compiled 5 stocks from export-oriented sectors such as information technology (IT) and pharma sectors for you to look at positively:
Wed, Jun 13, 2018
Sun Pharma has received EIR from the United States Food and Drug Administration (USFDA) for the inspection conducted at the Halol facility during the period February 12-23, 2018, Sun Pharma said in a filing to BSE.
The Sensex and Nifty are expected to open lower tracking negative trend in Asian markets ahead of US Federal Reserve's policy outcome due later today. At 8:00 am, SGX Nifty was trading at 10,822, up 24.50 points or 0.23 per cent.
Fri, Jun 08, 2018
The Sensex ended at 35,443, down 19.41 points, while the broader Nifty50 settled at 10,767, down 0.70 points. In the broader market, the BSE Smallcap and the BSE Midcap indices gained 0.6 per cent and 0.4 per cent, respectively.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
